Navigation Links
Uroplasty Reports Third Quarter Fiscal 2009 Results
Date:2/3/2009

nternal managerial purposes because we believe such measures are one important indicator of the strength and the performance of our business as they provide a link to operating cash flow. We also believe that analysts and investors use such measures to evaluate the overall operating performance of companies in our industry, including as a means of comparing period-to-period results and as a means of evaluating our results with those of other companies.

Our non-GAAP operating loss for each of the three-month periods ended December 31, 2008 and 2007 was approximately $0.5 million. Compared to the year-ago period, an improvement in gross profit rate and a decrease in cash operating expenses were about offset by a decrease in sales. Our non-GAAP operating performance improved from a loss of approximately $1.5 million for the nine months ended December 31, 2007 to a loss of approximately $0.5 million for the same period in 2008. We attribute this improvement in non-GAAP operating performance to the increase in sales and an improvement in gross profit rate, offset partially by an increase in cash operating expenses.



                            Three Months Ended       Nine Months Ended
                                December 31,              December 31,
                             2008         2007         2008         2007

    Gross Profit
      GAAP gross
       profit           $2,853,298   $2,939,359  $10,042,269   $7,664,323
      % of sales                84%          79%          85%          79%
      SFAS 123(R)
       share-based
       compensation          8,879        9,008       34,132       18,695
      Depreciation
       expenses             12,436       13,277       38,283       41,882
      Non-GAAP gross
       profit            2,874,613    2,961,644   10,114,684    7,724,900
    Operating Expenses
      GAAP operating
       expenses          3,774,118    3,868,656   12,012,296  $
'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York
2. Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
3. Uroplasty to Host Third Quarter Conference Call on February 11
4. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
5. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
6. Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading
7. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
8. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
9. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
10. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
11. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Conn., Oct. 12 Boehringer Ingelheim today,announced ... honors by Science as the,world,s most respected ... 470 Top Employers polls employees in the ... web-based survey are asked to rate companies ...
... enzyme TPPII may contribute to obesity by stimulating the formation ... week. The enzyme, TPPII, has previously been linked to making ... that it may be even more deeply involved in causing ... formation of fat cells in worms and mammalian cells and ...
... 11 IsoTis, Inc.,(NASDAQ: ISOT ) ("IsoTis"), an ... meeting of stockholders it called to approve,the acquisition of ... ("Integra") pursuant to an agreement and plan of merger,dated ... of stockholders was held at 9 a.m. Pacific time,today. ...
Cached Biology Technology:Boehringer Ingelheim Receives Top Honor as World's Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey 2Boehringer Ingelheim Receives Top Honor as World's Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey 3IsoTis Adjourns Special Meeting to October 23, 2007 2IsoTis Adjourns Special Meeting to October 23, 2007 3IsoTis Adjourns Special Meeting to October 23, 2007 4
(Date:4/17/2014)... White House honored Clemson professor Rajendra Singh Thursday ... to promote and expand solar deployment in the ... D. Houser Banks Professor of Electrical and Computer ... Nanoelectronics, is considered a local hero leading the ... economic opportunity in solar power and driving policy ...
(Date:4/17/2014)... conditions such as heart disease, epilepsy and pain, making ... there is still much scientists do not know about ... insight into the structure of sodium channels and, specifically, ... are responsible for ,fine-tuning, the activity of the channel. ... of the Journal of Biological Chemistry . , ...
(Date:4/17/2014)... Researchers at the University of Texas Medical Branch ... young women treated with radiation for cervical cancer ... recommended. , The UTMB researchers, finding a ... cancer survivors treated with radiation, offer new recommendations ... colorectal cancer screening about eight years after their ...
Breaking Biology News(10 mins):White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2
... JUPITER, FL, December 28, 2010 Scientists from the ... molecular interaction between a structural hepatitis C virus protein (HCV) ... strongly suggests a novel method of inhibiting the production of ... C drug development. The study was published in ...
... Woody ornamental plants with colorful or unusually shaped stems, ... in cut flower production markets. These unique plants can ... such as extended growing seasons, respectable financial returns, hardiness, ... plantings. A research team from the Department of ...
... years of cooperative research on the exotic invasive, ... Service,s Pacific Southwest Research Station (PSW) recently published ... A Summary of the Literature." This 181-page comprehensive ... a history of sudden oak death, identification and ...
Cached Biology News:Scripps Research scientists identify key interaction in hepatitis C virus 2Willow cut-stem growers surveyed 2Comprehensive report on sudden oak death 2
... utilizies CTI Molecular Imaging's proprietary Focus™ ... sensitivty, and a large imaging volume ... to image multiple mice or large ... a dedicated small animal PET (Positron ...
... a convenient and affordable alternative for diagnostic ... an eight-port disposable manifold, the StatMatic I ... pipettes. The eight-port manifold, designed for 96-well ... 200, 250, or 300mL with well-to-well accuracy ...
... (MOPS Buffered) has been developed specifically for ... solution. HRP Stabilizer prevents the loss ... of the antibody or protein antigen portion ... at 0.2 microns., ,Contents: Aqueous, protein-containing ...
384 Well PCR Plate Carrier for Thermo-Sealer...
Biology Products: